Public health practitioners combine proven interventions to tackle complex health challenges using new framework
Peer-Reviewed Publication
Updates every hour. Last Updated: 24-Dec-2025 14:11 ET (24-Dec-2025 19:11 GMT/UTC)
Vast resources have gone into developing and testing medical and public health interventions so they can be used confidently as evidence-based practices. Yet many interventions are deployed in isolation—even when the people they aim to help often face multiple, overlapping health challenges. A new study led by researchers at Columbia School of Public Health introduces an innovative method designed to increase the use and impact of evidence-based practices by combining them into stronger, multi-component programs.
Chinese chemists boost lignin’s sun protection factor from 5 to 66 and cut colour darkness by one-third through controlled radical grafting and TiO₂ nano-loading, offering a biodegradable alternative to petrochemical filters.
Reporting in the Journal of Bioresources and Bioproducts, researchers show that atom-transfer radical polymerisation couples waste-pulp lignin with the commercial UV absorber MBBT, producing sub-micron spheres that remain stable after three hours of intense ultraviolet irradiation.
Researchers review how hydrogel-based wearable devices can collect and analyze sweat to monitor health biomarkers like glucose, lactate, and electrolytes. These flexible, biocompatible sensors offer a non-invasive alternative to blood tests for real-time health tracking.
This study uncovers a new molecular mechanism by which the E3 ubiquitin ligase PIAS4 orchestrates pluripotency exit and lineage commitment in porcine embryonic stem cells (pESCs). Using a genome-wide CRISPR screening approach, the researchers identified PIAS4 as a critical regulator that modulates histone H3K4me3 marks via SUMOylation-mediated stabilization of KDM5B. Loss of PIAS4 impaired stem cell differentiation, disrupted lineage specific gene programs, and altered mesendoderm specification through LEFTY2–SMAD signaling. These findings not only provide fundamental insight into porcine stem cell biology but also pave the way for applications in livestock breeding, artificial meat production, and regenerative medicine.
We all know stress can worsen pain, but new research shows that anger and a sense of injustice may be even more powerful triggers. In a study of more than 700 people living with chronic pain, researchers uncovered four distinct “anger profiles” that help explain why some patients hurt more, and longer, than others. Those who felt wronged or unfairly treated by their condition were the most likely to report severe, persistent pain months later. The findings suggest that learning to understand and manage anger could be essential to healing.
The senescence of bone marrow-derived mesenchymal stem cells is involved in osteoporosis. The combination of dasatinib and quercetin has been explored to alleviate bone loss by efficiently reducing senescent cell populations. However, senolytic therapy by dasatinib and quercetin requires a precise ratio for better therapeutic effects, which is hard to achieve by oral administration. Meanwhile, the poor water solubility of these compounds limits their bioavailability, and their non-specific action could hamper effective penetration and targeting within relevant tissues. Herein, we developed alendronate-functionalized liposomes carrying dasatinib and quercetin (Aln-Lipo-DQ), focusing mainly on senescence-associated osteoporosis induced by chemotherapy or radiotherapy. Alendronate helps liposomes deliver dasatinib and quercetin to the femur and tibias, effectively removing senescent cells from bone tissue and increasing bone volume fraction from 5.05% to 11.95% in the chemotherapy-induced osteoporosis mouse model. We also found a 2.91-fold increase in bone volume fraction in Aln-Lipo-DQ treated groups compared to the control in radiotherapy models. This selectively targeting bone and reducing senescent cells holds great promise for cancer treatment-related and senescence-associated bone disorders.
Researchers have discovered a novel role of Neuraminidase 1 (NEU1) in the pathophysiology of acute lung injury (ALI) and uncovers NEU1 as a direct target of baicalin and Huanglian Jiedu Decoction (HLJDD) in alleviating ALI. NEU1 binding to the CXCR4 protein, thereby activating the downstream JNK signaling pathway, promoting inflammation and endothelial barrier damage; whereas baicalin can enhance the degradation of NEU1 protein via the lysosomal pathway, thereby improving endothelial dysfunction and acute lung injury.